Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

2018-09-11 02:23:12 | BioPortfolio

Published on BioPortfolio: 2018-09-11T02:23:12-0400

Clinical Trials [328 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase

The present clinical trial will be conducted to compare the bioavailability of rivastigmine and assess bioequivalence at steady-state of the Test product RIV-TDS 13.3 mg/24 h and the marke...

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

The purpose of this bioequivalence study is to compare the test of Rivastigmine 1.5 mg Capsules of Dr.Reddy's Laboratories Limited with reference to Exelon 1.5 mg of Novartis in Healthy Su...

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

This is a bioequivalence study of Rivastigmine 1.5 mg capsules and Exelon Administered as 1.5 mg capsule in Healthy subjects under fasting conditions.

Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers

The purpose of this study was to determine the bioequivalence of two azilsartan formulations after administration of single doses to healthy subjects under fasted and fed conditions. These...

Exelon Patch and Combination With Memantine Comparative Trial

The primary objective is to compare the tolerability between rivastigmine patch monotherapy and combination therapy with memantine in patients with Alzheimer's disease (AD). The secondary ...

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

Past, present and future of bioequivalence: Improving assessment and extrapolation of therapeutic equivalence for oral drug products.

The growth in the utilization of systems thinking principles has created a paradigm shift in the regulatory sciences and drug product development. Instead of relying extensively on end product testing...

Determination of Voriconazole in Human Plasma and Its Bioequivalence by HPLC-MS/MS.

To develop a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for the determination of voriconazole in human plasma and its bioequivalence.

Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products.

Bioequivalence implementation in developing countries where a high proportion of similar drug products are being marketed has found several obstacles, impeding regulatory agencies to move forward with...

Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil or Caelyx in advanced ovarian cancer.

To compare the pharmacokinetic bioequivalence and safety of a generic pegylated liposomal doxorubicin formulation (SPIL DXR hydrochloride liposome injection) with that of the reference products, Caely...

The effect of the composition of a fixed dose combination on bioequivalence results.

The purpose of this work was to develop a new supergeneric product Meloxicam/Omeprazole. Such a combination brings a benefit in terms of decreasing side effects for the patients using meloxicam. The n...

Medical and Biotech [MESH] Definitions

None available.

More From BioPortfolio on "Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)"

Quick Search


Searches Linking to this Trial